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Tobacco etch virus (TEV) encodes three proteinases that catalyze processing of the genome-encoded polypro-
tein. The P1 proteinase originates from the N terminus of the polyprotein and catalyzes proteolysis between
itself and the helper component proteinase (HC-Pro). Mutations resulting in substitution of a single amino
acid, small insertions, or deletions were introduced into the P1 coding sequence of the TEV genome. Deletion
of the N-terminal, nonproteolytic domain of P1 had only minor effects on virus infection in protoplasts and
whole plants. Insertion mutations that did not impair proteolytic activity had no measurable effects regardless
of whether the modification affected the N-terminal nonproteolytic or C-terminal proteolytic domain. In
contrast, three mutations (termed S256A, F, and D304) that debilitated P1 proteolytic activity rendered the
virus nonviable, whereas a fourth proteinase-debilitating mutation (termed C) resulted in a slow-infection
phenotype. A strategy was devised to determine whether the defect in the P1 mutants was due to an inactive
proteinase domain or due simply to a lack of proteolytic maturation between P1 and HC-Pro. Sequences coding
for a surrogate cleavage site recognized by the TEV NIa proteinase were inserted into the genome of each
processing-debilitated mutant at positions that resulted in NIa-mediated proteolysis between P1 and HC-Pro.
The infectivity of each mutant was restored by these second-site modifications. These data indicate that P1
proteinase activity is not essential for viral infectivity but that separation of P1 and HC-Pro is required. The
data also provide evidence that the proteinase domain is involved in additional, nonproteolytic functions.
Tobacco etch virus (TEV), a member of the Potyviridae
family of positive-strand RNA viruses, possesses a genome
encoding a single large polyprotein that is proteolytically pro-
cessed by three virus-specific proteinases (32). The require-
ment for three proteinases is intriguing, given that there is no
conceptual limitation to a polyprotein-producing virus’s re-
quiring only a single proteolytic enzyme, as do the como- and
nepoviruses (21). At least two selective advantages can be
envisioned that might have contributed to the acquisition and
maintenance of multiple proteinases through modular evolu-
tion (12). First, increasing the number of proteinases may have
provided an additional means to regulate proteolysis through
differential activities of the enzymes. Second, the different pro-
teinases may have been adopted to provide additional, non-
proteolytic viral functions. Several examples are now available
to support the latter idea. The picornavirus 3C proteinase
exhibits RNA-binding activity that may be necessary for initi-
ation of positive-strand RNA synthesis (2). Additionally, the
core domain of the Sindbis virus capsid protein is a serine-type
proteinase (11), illustrating that a proteinase can provide both
enzymatic and structural functions.
Multiple activities have been assigned to the potyviral pro-
teinases. The NIa proteinase is a picornavirus 3C-like protein-
ase that recognizes cleavage sites within the C-terminal two-
thirds of the polyprotein (6). The proteolytic domain of NIa
lies within the C-terminal half of the protein (6, 20), whereas
the N-terminal region contains the VPg (viral protein, ge-
nome-linked) activity (26, 34). The helper component protein-
ase (HC-Pro) contains a papain-like proteinase domain near
the C terminus (5, 28) and an N-terminal domain required for
aphid transmissibility of the virus (3, 35). This proteinase is
required for cleavage only at its C terminus.
The potyviral P1 proteinase was characterized recently as a
serine-type enzyme that catalyzes cleavage at a Tyr-Ser dipep-
tide between itself and HC-Pro (25, 38). The C-terminal half
(147 amino acid residues) of P1 contains the complete func-
tional proteinase, with a catalytic triad composed of His-214,
Asp-223, and Ser-256, whereas the N-terminal 157 amino acid
residues are dispensable for proteinase activity (37). The P1
proteinase cleaves preferentially by an autoproteolytic mecha-
nism, and its activity in vitro requires a cellular factor present
in extracts from plant (wheat germ) but not animal (rabbit
reticulocyte) cells (37). The P1 protein was shown to exhibit
nonspecific RNA-binding activity (4), although the domain
required for this function is not known. Among different po-
tyviruses, the P1 protein is the least conserved region of the
entire polyprotein (16, 36). In fact, the N-terminal half of P1 is
hypervariable both in length and in sequence.
To understand the role of the potyvirus P1 protein in viral
infectivity, TEV mutants containing altered P1 coding se-
quences were generated. Mutants containing substitutions, in-
sertions, or deletions in the proteolytic and nonproteolytic
domains of P1 were analyzed for their abilities to infect iso-
lated cells and whole plants. The mutant genomes also en-
coded a reporter protein, b-glucuronidase (GUS), which al-
lowed quantitative analysis of viral replication and movement
through plants.
MATERIALS AND METHODS
Strains, plants, and plasmids. Most recombinant and mutagenized plasmids
were cloned in Escherichia coli HB101. Single-stranded plasmid DNA was pre-
pared from E. coli RZ1032 by infection with the defective phage M13K07.
Complementary DNA representing the TEV genome was described previously
(15). The numbering of all TEV nucleotides and amino acid residues, starting
from the genome 59 end and N terminus of the polyprotein, respectively, was
based on the published sequence (1). Nicotiana tabacum cv. Xanthi nc was used
for all whole-plant infections and protoplast isolations.
A series of eight mutations, resulting in three-amino-acid insertions in the P1
protein, were generated by oligonucleotide-directed mutagenesis (23) with the
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intermediate plasmid pTL7SN.3-0027DA-GUS (15). This plasmid contains an
SP6 promoter adjacent to cDNA representing TEV nucleotides 1 to 2681, with
the GUS coding sequence inserted between the P1 and HC-Pro regions. This
plasmid also contains cDNA from the 39-terminal 152 nucleotides of the genome
plus a poly(A)45 sequence immediately downstream from the larger TEV se-
quence. The insertions consisted of nine nucleotides (ACCATGGCA), contain-
ing an NcoI site and encoding a Thr-Met-Ala tripeptide. The sites of insertion
were after nucleotides 429, 522, 561, 615, 708, 792, 885, and 972 and were chosen
by a semirandom process that ensured that insertions were spaced no greater
than 100 nucleotides apart. These insertions were designated with the letter
codes A1, A2, A, B, C, D, E, and F, respectively. The S256A mutation, resulting
in substitution of Ala for Ser-256 at the active site of the P1 proteinase, was
described previously (38) and was subcloned into pTL7SN.3-0027DA-GUS by
using a BsiWI-BsiWI restriction fragment containing TEV nucleotides 479 to
940.
Three deletion mutations were produced by using pTL7SN.3-0027DA-GUS.
The D05 and D06 deletions were generated by removal of sequence between the
NcoI site flanking the start codon of the TEV open reading frame and the
introduced NcoI sites after nucleotides 561 and 615, respectively. The D304
deletion, which eliminated Tyr-304 at the C-terminal position of P1, was also
described previously (37).
Oligonucleotide-directed mutagenesis was conducted with pTL7SN.3-
0027DA-GUS plasmids carrying the S256A and F mutations to introduce the
sequence ACTGAGAATCTTTATTTTCAGAGC between the coding regions
for P1 and GUS. This insertion codes for Thr-Glu-Asn-Leu-Tyr-Phe-Gln-Ser,
the last seven amino acid residues of which function as an NIa proteinase
recognition site, with proteolysis occurring between the Gln and Ser residues (7,
17, 19). The names of all plasmids containing the NIa cleavage site coding
sequence at this position were given the suffix P12G.
The plasmid pTL7SN.3-0027DA-G2H contains the coding sequence for the
NIa cleavage site between the GUS and HC-Pro regions and was described
previously (10). The C, F, S256A, and D304 mutations were introduced into
pTL7SN.3-0027DA-G2H by site-directed mutagenesis.
Each point, insertion, and deletion mutation was introduced into a plasmid
containing the full-length TEV cDNA by the following strategy. The intermedi-
ate plasmid pTL7SN.3-0027DA-GUS, containing the P1 mutations, and similar
plasmids containing the NIa cleavage recognition sequences were digested with
BstEII, which cleaves the adjacent 59 and 39 cDNA fragments at TEV nucleotide
positions 1430 and 9467, respectively. The BstEII-BstEII fragment corresponding
to nucleotides 1430 to 9467 was excised from the full-length cDNA of pTEV7DA
(15) and inserted into the BstEII-digested pTL7SN.3-0027DA-GUS derivative.
All plasmids containing a full-length TEV cDNA and the GUS sequence were
named with the prefix pTEV7DAN-GUS. The plasmid pTEV7DAN-GUS/VNN,
containing a mutation resulting in substitution of Val-Asn-Asn for the highly
conserved Gly-347–Asp-348–Asp-349 in NIb polymerase, was described previ-
ously (10).
Four plasmids were constructed to analyze the GUS activity of P1/GUS,
GUS/HC-Pro, and P1/GUS/HC-Pro fusion proteins in protoplasts. pRTL2, the
base vector for these plasmids, contains a cauliflower mosaic virus 35S transcrip-
tional promoter and terminator (9). pRTL2-0027GUS contains an insertion of
cDNA representing TEV nucleotides 1 to 2681, including the GUS coding
sequence introduced between the P1 and HC-Pro coding regions. pRTL2-
0027GUS/S256A is identical to pRTL2-0027GUS except for a mutation convert-
ing the Ser-256 codon in P1 to one coding for Ala. pRTL2-P1GUS contains the
coding regions for P1 and GUS, including a functional P1 cleavage site. pRTL2-
P1GUS/303 is similar to pRTL2-P1GUS except that the P1-GUS fusion junction
lacks the sequence coding for Tyr-304 in P1, rendering the cleavage site between
P1 and GUS inactive (37). These plasmids were used for transient-expression
analysis in protoplasts as described previously (8).
In vitro transcription and translation. All transcripts were synthesized by
using SP6 RNA polymerase and plasmids purified by CsCl gradient centrifuga-
tion. Transcripts used to program in vitro translation reactions were synthesized
from BstEII-linearized plasmids. In vitro translation was carried out for 1 h at
258C with commercially prepared wheat germ extract (Promega) in the presence
of [35S]methionine (NEN-DuPont). After some translation reactions, NIa pro-
teinase was added and incubation was continued for 1 h at 308C. The proteinase
contained six His residues at the N terminus and was purified from a recombi-
nant E. coli strain by Ni21 affinity chromatography as described before (29).
Full-length transcripts were synthesized in the presence of 7-methylguanosine-
59-triphospho-59-guanosine by using BglII-linearized DNA (15). Transcripts were
used directly for whole-plant inoculations or concentrated fivefold by precipita-
tion with 2 M LiCl for protoplast inoculations (13).
Plant and protoplast inoculations. The relative amounts of parental and
mutant transcripts used in each experiment were normalized. Tobacco plants
were inoculated with transcripts (10 to 20 mg) by mechanical abrasion as in
earlier studies (13, 15). Tobacco protoplasts were prepared and inoculated by the
polyethylene glycol procedure as described before (8, 27) and maintained at
room temperature under constant fluorescent light.
Analysis of virus infection. Protoplasts were harvested at 24, 48, and 72 h
postinoculation (h.p.i.) by centrifugation and resuspended in GUS lysis buffer
(40 mM sodium phosphate, 10 mM EDTA, 0.1% Triton X-100, 0.1% sodium
lauryl sarcosine, 0.07% b-mercaptoethanol [pH 7.0]). GUS activity was assayed
by using the fluorometric substrate 4-methylumbelliferyl-b-D-glucuronide as de-
scribed before (8, 22). Activity values (picomoles of substrate cleaved per minute
per 105 protoplasts) were calculated from averages of replicate, contemporane-
ous samples, and the data were analyzed with a two-sample t test with the
StatView 4.0 program (Abacus Concepts, Inc.).
Virus infectivity in whole plants was analyzed by GUS activity assays as de-
scribed above; an immunoblot assay with anticapsid, anti-HC-Pro, and anti-GUS
sera (30); and by reverse transcriptase-PCR (RT-PCR) and nucleotide sequenc-
ing (14). In some experiments, GUS activity in inoculated or systemically in-
fected leaves was analyzed in situ by using the histochemical substrate 5-bromo-
4-chloro-3-indolyl-b-D-glucuronic acid cyclohexylammonium salt (X-gluc) and
the vacuum infiltration technique (15). For immunoblot assays, 1 g of upper
noninoculated leaves was ground in 5 ml of protein dissociation buffer (0.063 M
Tris-HCl [pH 6.8], 2% sodium dodecyl sulfate [SDS], 10% 2-mercaptoethanol,
10% glycerol). Extracts were subjected to SDS–12.5% polyacrylamide gel elec-
trophoresis, after which the proteins were transferred to nitrocellulose mem-
branes and incubated with antisera. Positive reactions were detected by using a
chemiluminescence system (Amersham, Inc.).
To conduct RT-PCR analysis, virus extracts were prepared from upper, non-
inoculated leaves obtained at 14 days postinoculation (d.p.i.) as described before
(18) but with the exclusion of the CsCl gradient step. Viral RNA was isolated by
proteinase K treatment followed by phenol extraction and ethanol precipitation.
With RNA from D05 and D06 mutant-inoculated plants, RT-PCRs were carried
out with a first-strand primer complementary to GUS nucleotides 387 to 407 and
a second-strand primer corresponding to TEV nucleotides 123 to 142 in the 59
noncoding region. Two separate RT-PCRs were conducted with RNA from C, F,
S256A, or D304 mutant-inoculated plants. The first reaction used the same
first-strand primer described above but a second-strand primer corresponding to
TEV nucleotides 523 to 538. The second RT-PCR used a first-strand primer
complementary to TEV nucleotides 2396 to 2415 within the HC-Pro coding
region and a second-strand primer corresponding to GUS nucleotides 1761 to
1778. Nucleotide sequencing of RT-PCR products was conducted to verify the
presence or absence of the P1 mutations, the NIa cleavage site insertion between
P1 and GUS sequences, and the NIa cleavage site insertion between GUS and
HC-Pro sequences.
RESULTS
Mutations in the P1 protein-coding region of the TEV ge-
nome. Twelve mutations were introduced into the P1 coding
region of pTEV7DAN-GUS, the full-length TEV cDNA-con-
taining plasmid from which parental TEV-GUS derives (15).
Eight insertions, each consisting of nine nucleotides encoding
the tripeptide Thr-Met-Ala, were introduced separately into
the P1 region at approximately 90-bp intervals and were rep-
resented by the letter codes indicated in Fig. 1A. Insertions A1,
A2, and A modified the N-terminal nonproteolytic region,
while the remaining insertions affected the proteolytic domain.
Notably, mutation F resulted in an insertion between Phe-276
and Ile-277 within the sequence Phe-Ile-Val-Arg-Gly, a motif
that is highly conserved among potyviruses, deletion of which
was shown to inhibit P1 proteolysis (38). A substitution muta-
tion (S256A) resulted in conversion of Ser-256 to Ala at the P1
active site and was shown previously to inactivate the protein-
ase (38). Three deletion mutations, resulting in removal of 139
or 157 amino acid residues from the nonproteolytic domain
(D05 and D06, respectively) or only the C-terminal Tyr-304
residue, were also introduced (Fig. 2A).
To analyze the effects of these mutations on P1 processing,
transcripts from BstEII-linearized plasmids were translated in
a wheat germ extract. Transcripts from the parental plasmid
and those containing the insertion and substitution mutations
encoded a 117-kDa polyprotein consisting of P1, GUS, and a
14-kDa segment of HC-Pro. Translation of transcripts encod-
ing an active P1 proteinase should result in the accumulation of
the 35-kDa P1 protein and the 82-kDa GUS/HC-Pro fusion
protein. Processed products were detected after translation of
transcripts from the parental plasmid as well as A1, A2, A, B,
D, and E mutant plasmids (Fig. 1B). Translation of transcripts
from S256A, C, and F mutant plasmids resulted in accumula-
tion of a stable 117-kDa polyprotein (Fig. 1B), even after an
additional 15 h of incubation. The inhibitory effects of the
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S256A and F mutations were consistent with previously pub-
lished results (38).
Translation of transcripts from the D05 and D06 deletion
mutant plasmids resulted in processed products corresponding
to truncated but proteolytically active P1 polypeptides and the
GUS/HC-Pro fusion product (Fig. 2B). Conversely, translation
of transcripts from the D304 mutant plasmid resulted in accu-
mulation of only the 117-kDa P1/GUS/HC-Pro polyprotein
(Fig. 2C).
GUS as a reporter. In previous studies, the GUS reporter
was used extensively as a quantitative tool to measure parental
and mutant TEV genome amplification in inoculated proto-
plasts (10, 13, 31). As GUS and TEV proteins are synthesized
in stoichiometric quantities, and since TEV proteins and
genomic RNA accumulate proportionally (14), GUS is a par-
ticularly useful reporter of genome amplification. Parental
TEV-GUS encodes a polyprotein in which proteolysis by P1
and HC-Pro results in accumulation of a stable GUS/HC-Pro
fusion product (15). The P1 proteinase-defective mutants,
however, encode a polyprotein in which P1 fails to autopro-
teolytically separate from GUS, yielding a stable P1/GUS/HC-
Pro polyprotein.
To compare the relative activities of proteins containing P1
and/or HC-Pro fused to GUS, four plasmids suitable for tran-
sient-expression analysis in protoplasts were constructed. Two
plasmids encoded P1-active polyproteins that resulted in pro-
duction of nonfused GUS (pRTL2-P1GUS) or GUS/HC-Pro
FIG. 1. Mutations in the TEV P1 coding region and their effects on P1
proteolytic activity. (A) Diagrammatic representation of relevant portions of the
pTEV7DAN-GUS plasmid, including the SP6 promoter, TEV genomic cDNA
(open box), and the GUS coding sequence (solid box). The coding region for the
proteolytic domain of P1 is indicated by the stippled box. The positions of
sequences encoding P1, HC-Pro, and NIa proteinase cleavage sites are indicated
by vertical lines. The N-terminal coding sequence (to the BstEII site) is enlarged,
and the relative positions of P1 mutations are indicated by the letters. The
positions of codons for the proposed active-site residues (His-214, Asp-223, and
Ser-256) in the P1 proteinase are shown below the enlargement. The nucleotide
(nt) and corresponding amino acid (a.a.) insertion site positions within the P1
sequence are listed below the diagram. Abbreviations: P1, protein 1; HC-Pro,
helper component proteinase; P3, protein 3; CI, cylindrical inclusion protein; 6,
6-kDa protein; NIa, nuclear inclusion protein a; NIb, nuclear inclusion protein b;
Cap, capsid protein. (B) Cell-free translation and processing products encoded
by transcripts from BstEII-linearized plasmids containing the P1 mutations.
Translation reaction mixes were programmed with parental (wt) or mutant
transcripts, as indicated above each lane. [35S]methionine-labeled translation
products were analyzed by SDS–12.5% polyacrylamide gel electrophoresis and
fluorography. The electrophoretic positions of the 117-kDa P1/GUS/partial HC-
Pro polyprotein, the 82-kDa GUS/partial HC-Pro fusion protein, and the 35-kDa
P1 protein are indicated on the left. Whether or not processing occurred to
generate the P1 protein is indicated below each lane.
FIG. 2. Deletion mutations in the TEV P1 coding region and their effects on
P1 proteolytic activity. (A) Diagrammatic representation of relevant portions of
parental and deletion mutant plasmids, including the SP6 promoter, TEV
genomic cDNA (open box), and the GUS coding sequence (solid box). The
coding region for the proteolytic domain of P1 is indicated by the stippled box.
Note that the D304 mutant lacks the coding sequence for only Tyr-304. The
positions corresponding to RT-PCR primer sites (bent arrows) are indicated in
the TEV-GUS diagram. Abbreviations are the same as in the Fig. 1 legend. (B
and C) Cell-free translation and processing products encoded by transcripts from
BstEII-linearized plasmids containing deletions within the P1 sequence. Trans-
lation reaction mixes were programmed with parental (TEV-GUS) or mutant
transcripts, as indicated above each lane. [35S]methionine-labeled translation
products were analyzed by SDS–12.5% polyacrylamide gel electrophoresis and
fluorography. The electrophoretic positions of the 117-kDa P1/GUS/partial HC-
Pro polyprotein (P1/G/H), the 82-kDa GUS/partial HC-Pro fusion protein (G/
H), and the 35-kDa P1 protein are indicated on the left of each panel. The
truncated P1 proteins processed from the D05 and D06 polyproteins are shown
near the bottom of panel B. The P1 processing phenotype of each mutant is
indicated below the lanes.
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(pRTL2-0027GUS) (Fig. 3A). Two additional plasmids en-
coded P1-inactive polyproteins corresponding to P1/GUS/HC-
Pro (pRTL2-0027GUS/S256A) and P1/GUS (pRTL2-P1GUS/
303) (Fig. 3A). Protoplasts were transfected with equivalent
amounts of plasmid DNA, and GUS activity was measured
after 24 h. Whereas the activity in protoplasts accumulating
nonfused GUS or GUS/HC-Pro fusion protein was relatively
high and differed by only a factor of 2 (Fig. 3B, columns 1 and
3), the activity in protoplasts accumulating P1/GUS or P1/
GUS/HC-Pro fusion proteins was markedly low (Fig. 3B, col-
umns 2 and 4). In fact, GUS activity directed by P1/GUS/HC-
Pro (column 2) was nearly 350 times lower than that directed
by GUS/HC-Pro (column 1). These data strongly suggest that
fusion of P1 to the N terminus of GUS inhibits GUS activity in
vivo, although fusion of HC-Pro to the C terminus has rela-
tively little effect. Consequently, the GUS activity assay to
measure genome amplification in protoplasts was used only for
the proteolytically active P1 mutants.
Infectivity of proteolytically active P1 mutants. Amplifica-
tion of the six insertion mutant (A1, A2, A, B, D, and E) and
two deletion mutant (D05 and D06) genomes encoding active
P1 proteinases was measured by using the fluorometric GUS
assay. Protoplasts were inoculated with transcripts synthesized
from BglII-linearized plasmids, and GUS activity was quanti-
fied at 24, 48, and 72 h.p.i. In each experiment, transcripts
representing TEV-GUS were used as the positive amplification
control, while transcripts representing TEV-GUS/VNN were
used as negative amplification controls. The latter contained a
mutation inactivating the viral RNA polymerase (NIb); tran-
scripts from these plasmids were shown previously to be am-
plification defective (10).
Parental TEV-GUS and each of the six insertion mutant
genomes were amplified in protoplasts, with similar accumu-
lation profiles over the 72-h incubation (Fig. 4A to D). None of
these mutants was significantly different from TEV-GUS (P .
0.25). The D05 and D06 deletion mutant genomes were also
amplified, although at levels lower than that of TEV-GUS
(Fig. 4E). The modest reduction in amplification levels was
consistent in multiple experiments, although the differences
between these deletion mutants and parental virus were not
always statistically significant (0.037 , P , 0.49). It is impor-
tant to note that valid comparisons of parental and mutant
genome amplification were made with data from concomitant
infections with the same protoplast preparation. Protoplasts
prepared from different plants varied in their apparent suscep-
tibility, as reflected in the differences in absolute GUS activity
levels in the different panels of Fig. 4; however, relative levels
of parental and mutant genome amplification were consistent
in different experiments.
Tobacco plants were inoculated mechanically with tran-
scripts representing parental TEV-GUS and each of the P1
proteolytically active insertion and deletion mutants. Plants
were assayed for infection by visual observation of symptoms
and analysis of GUS activity in upper, noninoculated leaves at
14 d.p.i. Parental TEV-GUS and each of the insertion mutants
infected at least 70% of the plants inoculated, with systemic
symptoms appearing at 5 to 7 d.p.i. (Table 1). Both the D05 and
D06 mutants were infectious, even though they lacked approx-
imately half of the P1 sequence. The infectivity of these two
deletion mutants was further verified by RT-PCR analysis with
extracts from systemically infected leaves. The 59 primer cor-
responded to sequences within the 59 nontranslated region,
while the 39 primer was complementary to sequences within
the GUS coding region. Products of approximately 1,317, 899,
and 845 bp were amplified from extracts of plants infected by
TEV-GUS, the D05 mutant, and the D06 mutant, respectively,
confirming the viability of the D05 (lacking 418 nucleotides)
and D06 (lacking 472 nucleotides) mutants (data not shown).
These data indicate that the N-terminal nonproteolytic domain
is dispensable for genome amplification and systemic infectiv-
ity.
Infectivity of the proteolytically defective P1 mutants. Be-
cause of the low activity of P1/GUS fusion proteins (Fig. 3),
GUS was not a useful reporter of genome amplification for the
P1 proteinase-defective mutants. Additionally, immunoblot
and RNA blot analyses were insufficiently sensitive to quantify
viral protein and RNA accurately after inoculation of proto-
plasts with synthetic transcripts (data not shown). Therefore,
the proteolytically inactive mutants were analyzed only in
whole plants. Tobacco plants were inoculated with transcripts
corresponding to the S256A, C, F, and D304 mutants, and
immunoblot analysis with anticapsid serum was conducted to
analyze infection in upper, noninoculated leaves at 14 and 32
d.p.i. Virus was not detected at either time point in plants
inoculated with the S256A, F, or D304 mutant (Table 2). No
virus was detected at 14 d.p.i. in systemic tissue of plants
inoculated with the C mutant, but 17% of C mutant-inoculated
plants became systemically infected by 32 d.p.i. (Table 2). This
mutant induced mild symptoms, and the amount of capsid
protein was relatively low compared with that of the parental
virus. A low level of GUS activity was also detected in system-
ically infected leaves at 32 d.p.i.
Infection by the C mutant was analyzed further by in situ
histochemical GUS assays (15) to visualize infection sites in
inoculated and systemic leaves at 4, 8, 16, and 32 d.p.i. (Fig. 5).
FIG. 3. Relative GUS activity of four polyproteins containing P1, GUS, and
HC-Pro. (A) Diagrammatic representation of relevant portions of four pRTL2-
based plasmids, including the cauliflower mosaic virus 35S promoter and the
coding sequences for P1, GUS, and HC-Pro. The positions of the P1 proteinase-
debilitating S256A and 303 mutations are indicated by the asterisks. The identity
of each pRTL2-derived plasmid is indicated on the left. The translation and
processing products derived from these plasmids are indicated on the right. (B)
GUS activity in tobacco protoplasts transfected with each pRTL2-derived plas-
mid. The numbers below each column correspond to the construct number in
panel A. Cells were harvested and GUS activity was measured at 24 h posttrans-
fection. The data shown are averages for three contemporaneous transfections.
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At 4 d.p.i., parental TEV-GUS had spread from the initial
infection foci to secondary sites through the vasculature of the
inoculated leaves (Fig. 5A). Infection foci of the C mutant
were confined to an average diameter of six epidermal cells
(Fig. 5A). At 8 d.p.i., the C mutant foci had enlarged to diam-
eters averaging 31 epidermal cells, with no detectable vascula-
ture-associated movement (Fig. 5B). The C mutant appeared
to invade vasculature-associated cells by 16 d.p.i., although
sites distal to the initial infection foci remained free of virus
(Fig. 5C). Invasion of the C mutant into systemic leaves was
detected at 32 d.p.i. (Fig. 5D). Compared with that by the
parental virus, the extent of systemic infection by the C mutant
was limited. Because of the low level of C mutant virus in these
plants, immunoblot analyses with anti-GUS and anti-HC-Pro
sera to determine whether P1 proteinase was partially active in
vivo were inconclusive.
Introduction of NIa cleavage sites to restore processing.
There are several possible reasons for the correlation between
inactivation of the P1 proteinase and debilitation of infectivity
in plants. First, successful infection may require that the P1
proteinase and HC-Pro be separated or that a mature C ter-
minus of P1 be formed. As TEV-GUS, which encodes a stable
GUS/HC-Pro fusion protein in infected cells, is clearly viable,
there appears to be no strict requirement for formation of a
mature HC-Pro N terminus. Second, infection may depend on
the P1 proteinase’s cleaving additional polyprotein sites be-
sides the one located at the C terminus of P1. At present, no
such sites have been identified. Third, additional, nonproteo-
lytic functions of the proteolytic domain may be debilitated by
mutations that also inactivate the P1 proteinase.
To determine if there is a requirement for an active P1
proteinase or merely for separation of P1 from HC-Pro, se-
quences coding for NIa-mediated cleavage sites were intro-
duced into the proteinase-debilitated mutant genomes as well
as into the parental TEV-GUS genome. The NIa sites were
inserted at either of two positions in the viral genomes. The
first position was between the GUS and HC-Pro sequences,
resulting in TEV-G2H (wild-type P1), TEV-G2H/S256A,
TEV-G2H/C, TEV-G2H/F, and TEV-G2H/D304 (Fig. 6A).
As shown previously, a functional cleavage site at this position
facilitates separation of HC-Pro from P1 and GUS by NIa-
mediated proteolysis (10). The second cleavage site insertion
position was between P1 and GUS, resulting in the TEV-
P12G derivatives (Fig. 6A). A cleavage site at this position
FIG. 4. Amplification of parental and P1 mutant genomes in protoplasts. GUS activity was measured at 24, 48, and 72 h.p.i. The data shown in each panel are
averages from one of two or three replicated experiments. All mutants were tested in parallel with parental TEV-GUS and VNN mutant genomes as positive and
negative amplification controls, respectively.
TABLE 1. Infectivity of proteolytically active P1 mutants in plants
Inoculum No. of plants infected/no. inoculateda
Onset of symptoms
(d.p.i.)
TEV-GUS 72/79 5–6
A1 7/10 7
A2 10/10 5
A 10/10 6
B 19/20 6
D 7/10 7
E 8/10 6
D05 5/13 7
D06 11/16 7
a The appearance of symptoms and detection of GUS activity in upper, noni-
noculated leaves were scored as a positive infection.
TABLE 2. Infectivity of proteolytically defective
P1 mutants in plants
Inoculum No. of plants infected/no. inoculateda
Onset of symptoms
(d.p.i.)
TEV-GUS 7/7 6
S256A 0/10
F 0/10
C 2/12 32
D304 0/10
a The appearance of symptoms and detection of coat protein by immunoblot
analysis of extracts from upper, noninoculated leaves at 32 d.p.i. were scored as
a positive infection.
1586 VERCHOT AND CARRINGTON J. VIROL.
should result in separation of mature P1 from GUS/HC-Pro.
Therefore, these viruses permit investigation of the require-
ment for proteolytic separation of P1 and HC-Pro indepen-
dently of the requirement for P1 proteolytic activity.
To verify that the introduced cleavage sites were functional,
translation products were synthesized from transcripts of
BstEII-linearized plasmids corresponding to each of the paren-
tal or modified genomes and reacted with purified NIa pro-
teinase. The transcripts encoded a P1/GUS/partial HC-Pro
polyprotein (117 kDa). Figure 6B shows the results of trans-
lation and processing of the parental and S256A derivatives. In
the absence of NIa proteinase, each of the P1 proteolytically
active derivatives yielded mature P1 and GUS/HC-Pro (Fig.
6B, lanes 2, 4, and 6), whereas the 117-kDa polyproteins en-
coded by the S256A derivatives were stable (lanes 3, 5, and 7).
As noted in previous studies (37, 38), the P1 protein migrated
during electrophoresis as a doublet. Translation products de-
rived from transcripts of TEV-GUS and its S256A counterpart
were unaffected by NIa proteinase (Fig. 6B, compare lanes 2
and 3 with 9 and 10). In contrast, translation products from
transcripts of TEV-G2H and its S256A derivative were pro-
cessed by NIa, yielding mature GUS and P1/GUS fusion pro-
tein, respectively (lanes 11 and 12). Translation products from
transcripts of TEV-P12G and its S256A counterpart were also
processed by NIa. In the TEV-P12G/S256A polyprotein, P1
and GUS/HC-Pro were generated (Fig. 6B, lane 14), with the
electrophoretic mobility of P1 decreased slightly by the addi-
tional sequence from the NIa cleavage site. The parental TEV-
P12G polyprotein contained a functional P1 proteinase cleav-
age site plus the NIa cleavage site, and in a minor percentage
of these polyproteins the NIa site was the only one processed
(lane 13). The functionality in vitro of the introduced NIa
cleavage sites encoded by the C, F, and D304 mutant genomes
was also confirmed (data not shown).
To test the abilities of the modified viruses to infect tobacco
systemically, upper leaves of transcript-inoculated plants were
analyzed at 14 d.p.i. by either immunoblot assay with anticap-
sid serum or RT-PCR to detect viral RNA corresponding to a
947-nucleotide region containing both P1 and GUS sequences.
At least 86% of plants inoculated with transcripts representing
the parental viruses encoding an active P1 proteinase, either
with (TEV-G2H and TEV-P12G) or without (TEV-GUS)
an introduced NIa cleavage site, were infected (Table 3). As
noted above, the proteolytically inactive TEV-GUS/S256A
mutant was unable to infect plants systemically. However, the
S256A mutants containing the NIa cleavage site insertions
were viable, infecting at least 73% of inoculated plants (Table
3). While the TEV-GUS/D304 mutant was inactive, the TEV-
FIG. 5. In situ localization of GUS activity in leaves of plants inoculated with parental TEV-GUS or mutant C transcripts. Inoculated or systemically infected leaves
were vacuum infiltrated with X-gluc substrate at 4, 8, 16, and 32 d.p.i. The blue areas indicate sites of infection. The infecting virus (TEV-GUS or mutant C virus) is
indicated below each panel.
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G2H/D304 mutant infected 41% of inoculated plants (Table
3). Immunoblot analysis with anti-GUS and anti-HC-Pro sera
indicated that the NIa cleavage sites were processed properly
in each set of infected plants (data not shown). Although the
TEV-GUS/F mutant was noninfectious, viability was restored
by insertion of the NIa cleavage site between P1 and GUS in
TEV-P12G/F, as revealed by 25% infected plants. Interest-
ingly, no plants were infected after inoculation with TEV-
G2H/F transcripts encoding the NIa cleavage site between
GUS and HC-Pro (Table 3). The nonviability of TEV-G2H/F
was shown to be a result solely of the F mutation rather than
a cryptic mutation elsewhere in the genome, as a site-specific
revertant with the wild-type sequence restored was fully infec-
tious (data not shown). Sequence analysis of RT-PCR products
from each of the infectious modified genomes indicated that
the S256A, D304, and F mutations were retained in the prog-
eny, as were the introduced NIa cleavage site sequences. These
results indicate that neither P1 proteolytic activity nor a func-
tional P1 proteinase cleavage site is necessary for virus infec-
tivity, provided that separation of P1 from HC-Pro is catalyzed
by another proteinase.
Systemic infection was detected in 1 of 10 plants inoculated
with TEV-GUS/C at 14 d.p.i. The RT-PCR analysis of the
infected plant yielded a relatively weak signal, and the immu-
noblot assay failed to detect capsid protein (Table 3), indicat-
ing that virus accumulation was extremely low. In contrast,
90% of plants inoculated with the TEV-G2H/C transcripts
were infected systemically, as revealed by strong immunoblot
and RT-PCR signals (Table 3). These data suggest that infec-
tivity was enhanced by insertion of the NIa cleavage site. Sur-
prisingly, immunoblot analysis with anti-GUS serum revealed
that free GUS accumulated in TEV-G2H/C-infected plants
(Fig. 7, lane 4), just as in plants infected by parental TEV-
G2H encoding a wild-type P1 proteinase (lanes 2 and 3). This
indicates that the P1 proteinase containing the C insertion was
active in vivo, in contrast to its activity in vitro (Fig. 1). How-
ever, the relative efficiency of the C mutant proteinase relative
to the wild-type proteinase could not be determined.
DISCUSSION
A variety of mutations were introduced into the P1 coding
sequence of TEV. Mutants that encoded an active P1 protein-
ase had no identifiable phenotype distinct from that of parental
virus in protoplasts and plants. The most dramatic mutations
FIG. 6. Insertion of sequences encoding NIa proteinase cleavage sites into
parental and P1 mutant genomes. (A) Diagrammatic representation of relevant
portions of plasmids containing the introduced cleavage site sequences. Three
sets of plasmids were produced. In set 1, parental TEV-GUS and its S256A, C,
F and D304 mutant derivatives were the same as those shown in Fig. 1 and 2. In
set 2, TEV-G2H and its mutant derivatives encoded the NIa cleavage recogni-
tion sequence E-N-L-Y-F-Q-S between the GUS and HC-Pro coding regions
indicated below the plasmid diagrams. In set 3, TEV-P12G and its S256A and
F derivatives encoded the NIa cleavage recognition sequence between the P1 and
GUS coding regions. The exact position of NIa cleavage between the Q and S
residues is indicated. Expected translation and processing products derived from
each plasmid are indicated on the right. (B) Cell-free translation and processing
products encoded by BstEII-linearized transcripts from TEV-GUS, TEV-G2H,
and TEV-P12G and the corresponding S256A mutant derivatives of each.
[35S]methionine-labeled proteins were synthesized in a wheat germ extract for 1
h. Half of each reaction mix was treated for an additional 1 h with either water
(lanes 1 to 7) or NIa proteinase (lanes 8 to 14), and radiolabeled proteins were
analyzed by SDS–12.5% polyacrylamide gel electrophoresis and fluorography.
Translation reaction mixes programmed with no RNA are shown in lanes 1 and
8. The electrophoretic positions of the P1/GUS/partial HC-Pro polyprotein (P/
G/H), GUS/partial HC-Pro (G/H) fusion protein, and P1 protein, which were
produced in reactions in the absence of NIa proteinase, are indicated on the left.
The electrophoretic positions of the P1/GUS (P/G), GUS (G), and P1 generated
after addition of NIa proteinase are indicated on the right.
TABLE 3. Restoration of infectivity of P1 proteinase-debilitated
mutants by insertion of NIa cleavage sites
Inoculum
No. of plants infected/
no. inoculateda
No. of
products
sequencedb
Total no. of plants
infected/total no.
inoculatedcImmunoblot RT-PCR
TEV-GUS 19/19 5/5 2 24/24
TEV-G2H 9/9 3/3 1 12/12
TEV-P12G 17/21 7/7 2 24/28
TEV-GUS/S256A 0/5 0/8 0/13
TEV-G2H/S256A 6/6 7/7 3 13/13
TEV-P12G/S256A 4/8 7/7 3 11/15
TEV-GUS/D304 0/14 0/2 0/16
TEV-G2H/D304 5/17 4/5 2 9/22
TEV-GUS/C 0/10 1/4 1 1/10
TEV-G2H/C 9/10 4/4 2 9/10
TEV-GUS/F 0/11 0/7 0/18
TEV-G2H/F 0/9 0/9 0/18
TEV-P12G/F 3/12 2/6 2 5/18
a Immunoblot analysis was conducted with antibodies against GUS, HC-Pro,
and capsid protein. RT-PCR was carried out with RNA isolated from crude
virion preparations.
b The sequences through the sites of mutation and cleavage site insertion in
the P1 mutant genomes and at the corresponding positions in the parental
TEV-GUS genome were confirmed by using the RT-PCR products generated
from RNA templates isolated from crude virion preparations. The numbers of
RT-PCR products sequenced from independent plants are given. The P1 muta-
tions and NIa cleavage sites were confirmed in all RT-PCR products sequenced.
cWith the exception of the C mutant series, different plants were subjected to
immunoblot and RT-PCR analyses. For the C mutants, all plants were analyzed
by immunoblot, and a subset were also analyzed by RT-PCR.
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that had little effect were the D05 and D06 deletions, which
removed most of the hypervariable N-terminal half of P1. Not
surprisingly, insertions of tripeptides into the nonproteolytic
domain also had no effects. These data clearly indicate that the
N-terminal half of P1, as well as the RNA sequence coding for
this region, are nonessential for TEV replication or movement
in plants. While the role of this P1 domain is unclear, it may
provide a regulatory function involved in fine tuning of the
viral replicative cycle. This domain may also exert a quantita-
tive effect on putative functions of the C-terminal domain (see
below) by influencing P1 properties such as turnover or struc-
tural stability.
Conversely, mutants that encoded a defective P1 proteinase
were debilitated in plants. Infectivity was abolished by the
S256A, F, and D304 mutations, whereas the C mutation limited
the extent of systemic infection and increased the time re-
quired for spread compared with the parental virus. These data
are most easily interpreted to indicate that either P1 proteo-
lytic activity or excision of P1 from the remainder of the viral
polyprotein is necessary for infectivity.
The infectivity of the P1 proteinase-debilitated S256A, F,
and D304 mutants was restored by second-site mutations re-
sulting in insertion of a cleavage site recognized by the TEV
NIa proteinase. In this sense, it is appropriate to consider the
NIa cleavage site insertions as gain-of-function suppressor mu-
tations. The S256A mutation was suppressed by cleavage site
insertions either between P1 and GUS or between GUS and
HC-Pro. Several conclusions can be drawn from these results.
First, the P1 proteinase activity is not intrinsically required, as
a heterologous proteinase activity can substitute for the normal
P1 processing function. Second, TEV infectivity does not de-
pend on the P1 proteinase to catalyze proteolysis at other sites.
If P1 processing was required at additional positions, insertion
of the NIa cleavage sites only between P1 and HC-Pro would
not have rescued all P1 processing defects. Third, separation of
P1 from HC-Pro appears to be essential. In fact, from the
S256A restoration results, it appears that the exact site of
processing to separate P1 from HC-Pro is not critical.
If the proteinase activity of P1 is not intrinsically required,
why must P1 be separated from HC-Pro? We suggest that the
functions of HC-Pro and/or putative nonproteolytic functions
of P1 are debilitated when both P1 and HC-Pro are fused
within the same polyprotein. Failure to process may result in
mislocalization of one or both proteins within the cell. Alter-
natively, a processing defect may result in inactivation of HC-
Pro biochemical activities. HC-Pro carries out a number of
functions during the infection process. The C-terminal one-
third constitutes a cysteine-type proteolytic domain required
for autoproteolysis between HC-Pro and P3 (5). However,
previous results indicated that fusion of P1 to HC-Pro has no
effect on HC-Pro proteolytic function (38). The N-terminal
region of HC-Pro contains determinants necessary for aphid
transmissibility of the virus, although this function is not re-
quired for virus viability (3, 35). On the other hand, a number
of potyvirus mutants with substitutions or deletions within the
N-terminal two-thirds of HC-Pro exhibit replication defects in
protoplasts and plants (3, 14), suggesting that HC-Pro also
performs a role in genome amplification or gene expression.
In addition to debilitating HC-Pro, inhibition of processing
between P1 and HC-Pro may also inactivate a putative non-
proteolytic function of P1. It is logical to propose that the P1
protein carries out functions in addition to merely separating
itself from HC-Pro. Purified P1 protein expressed in E. coli
exhibits single-stranded-RNA-binding activity (4), although
the role of this activity during potyvirus genome expression or
amplification is not clear. In addition, the genetic data pre-
sented here support the hypothesis that the P1 proteolytic
domain is multifunctional. The S256A mutation was sup-
pressed relatively efficiently by NIa cleavage site insertions at
multiple positions, while the F mutation was suppressed inef-
ficiently, and only by insertion of the cleavage site between P1
and GUS. The differential effects of the S256A and F muta-
tions may be interpreted to mean that the P1 C-terminal do-
main is involved in proteolytic and nonproteolytic functions.
Such results would be predicted if the S256A mutation inhib-
ited only P1 proteolytic activity and the F mutation altered
proteolytic and nonproteolytic functions.
Does the P1 protein play a direct role in intercellular move-
ment of TEV? Despite considerable speculation (16, 24, 32,
33), experimental evidence implicating the P1 protein as a
transport factor is lacking. To date, only the capsid protein has
been shown to be required for virus movement in plants (13).
While the slow-infection phenotype of the C mutant might
indicate that P1 functions directly in movement, an alternative
scenario seems more likely. The slow-infection phenotype was
suppressed by NIa cleavage site insertion, indicating that the C
mutant defect was a function of protein processing rather than
debilitation of a ‘‘movement domain’’ within P1. Immunoblot
analysis of plants infected by a virus containing the C mutation,
however, revealed that the P1 proteinase was, in fact, func-
tional in vivo. These findings can be reconciled by proposing
that the P1 proteinase encoded by the C mutant was not in-
hibited completely, but rather possessed a slow processing ac-
tivity that indirectly affected other P1 and/or HC-Pro functions
required for infectivity. Given the variety of P1 mutants that
failed to exhibit specific defects in intercellular movement, it
seems doubtful that P1 plays an integral role in virus transport.
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FIG. 7. Immunoblot analysis of parental and mutant TEV-GUS-infected
plants. Total SDS-soluble proteins were extracted from systemic leaves of plants
infected by the viruses indicated above each lane. The immunoblots were probed
with anti-GUS serum. The electrophoretic positions of GUS-containing proteins
and their molecular masses (in kilodaltons) are indicated on the left. Note that
TEV-GUS encodes a stable GUS/HC-Pro (G/HC) fusion protein (lane 1),
whereas TEV-G2H encodes a GUS/HC-Pro polyprotein that undergoes NIa-
mediated proteolysis to yield mature-size GUS (G, lanes 2 and 3). Only mature-
size GUS was detected in TEV-G2H/C-infected plants (lane 4).
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